Inventory / revenue moved 59119 bp lower
Inventory / revenue changed -59119 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Inventory / revenue changed -59119 basis points from the comparable as-filed period.
Selling, general & administrative changed -19.3% from the comparable as-filed period.
Revenue changed +3022.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
Cash & equivalents changed +24040.3% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
Research & development changed -7.2% from the comparable as-filed period.
Gross profit changed +7366.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a low base.
Inventory changed +0.0% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.